Benzinga | Aug 24, 2021 06:04AM EDT

Chardan Capital Initiates Coverage On Tenaya Therapeutics with Buy Rating, Announces Price Target of $37

Chardan Capital analyst Geulah Livshits initiates coverage on Tenaya Therapeutics (NASDAQ:TNYA) with a Buy rating and announces Price Target of $37.